HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amy E Wright Selected Research

dictyostatin

1/2010Total synthesis of a library of designed hybrids of the microtubule-stabilising anticancer agents taxol, discodermolide and dictyostatin.
3/2009Total synthesis and biological evaluation of novel C2-C6 region analogues of dictyostatin.
12/2008Total synthesis and biological evaluation of potent analogues of dictyostatin: modification of the C2-C6 dienoate region.
10/2008Total synthesis of a potent hybrid of the anticancer natural products dictyostatin and discodermolide.
5/2007Synthesis and biological evaluation of novel analogues of dictyostatin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Amy E Wright Research Topics

Disease

17Neoplasms (Cancer)
01/2021 - 07/2003
10Pancreatic Neoplasms (Pancreatic Cancer)
01/2017 - 02/2009
2Colonic Neoplasms (Colon Cancer)
01/2021 - 11/2016
2Tuberculosis (Tuberculoses)
12/2019 - 01/2017
2Adenocarcinoma
01/2017 - 01/2017
1Triple Negative Breast Neoplasms
04/2021
1Malaria
03/2021
1Carcinoma (Carcinomatosis)
01/2021
1Disease Progression
01/2021
1Inflammation (Inflammations)
02/2015
1Adenocarcinoma of Lung
03/2007
1Leukemia
03/2007
1Sarcoma (Soft Tissue Sarcoma)
03/2007

Drug/Important Bio-Agent (IBA)

8Biological ProductsIBA
04/2021 - 03/2009
8Paclitaxel (Taxol)FDA LinkGeneric
02/2011 - 07/2003
5dictyostatinIBA
01/2010 - 05/2007
4MacrolidesIBA
01/2017 - 12/2008
3discodermolideIBA
01/2010 - 05/2007
2Pharmaceutical PreparationsIBA
03/2021 - 12/2019
2manzamine AIBA
09/2013 - 10/2011
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
03/2009 - 07/2003
2AldehydesIBA
03/2009 - 12/2008
1SurvivinIBA
01/2021
1dragmacidin GIBA
01/2017
1didemninsIBA
01/2017
1EnzymesIBA
01/2017
1ImmunosorbentsIBA
01/2017
1LuciferasesIBA
01/2017
1leiodermatolide CIBA
01/2017
1theopederin KIBA
01/2017
1nordidemnin BIBA
01/2017
1Interleukin-8 (Interleukin 8)IBA
01/2017
1GemcitabineFDA Link
11/2016
1PolyketidesIBA
11/2016
1leiodermatolideIBA
11/2016
1Antimitotic AgentsIBA
11/2016
1CytokinesIBA
02/2015
1Transcription Factors (Transcription Factor)IBA
02/2015
1NF-kappa B (NF-kB)IBA
02/2015
1microsclerodermin AIBA
02/2015
1Apoptosis Regulatory ProteinsIBA
02/2015
1Caspase 3 (Caspase-3)IBA
09/2014
1Proteins (Proteins, Gene)FDA Link
09/2014
1Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA
09/2013
1Adenosine Triphosphatases (ATPase)IBA
09/2013
1neopetrosiquinone AIBA
11/2011
1Docetaxel (Taxotere)FDA Link
01/2010
1lasonolide AIBA
11/2009
1aphrocallistinIBA
06/2009
1beta-ketophosphonateIBA
12/2008
110,11-dihydrodictyostatinIBA
03/2008
1neopeltolideIBA
03/2007
1Cytotoxins (Cytolysins)IBA
07/2003

Therapy/Procedure

3Therapeutics
03/2021 - 02/2009
1Immunotherapy
01/2019
1Drug Therapy (Chemotherapy)
02/2015